Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...

David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

Injected weight-loss drugs Wegovy, from Novo Nordisk, and Eli Lilly's Zepbound have U.S. list prices of over $1,000 a month.

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications ...

The calculus can be life-and-death; nearly 1,000 deaths a day are linked to diet-related ... recently introduced new discount programs. Early data suggest that the drugs may be useful in treating ...

He describes his weight loss and analyzes the drugs and their potential societal impact in his new book, “Diet, Drugs and Dopamine.” Kessler, who is 5 feet 10 inches tall, dropped more than 60 ...